Drug Trial Radar · NCT06873321
VTE Incidence After Rivaroxaban + Aspirin or SAPT After Lower-limb Revascularization
Last checked: Nov 20, 2026Latest source record: Mar 12, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
100
Planned (sponsor's estimate)
Start
Feb 24, 2024
Primary completion
Jul 20, 2025
Study completion Jul 30, 2025
Sponsor
- Lead sponsor
- Science Valley Research InstituteAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Mar 12, 2025
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (outcomes assessor)
- Primary purpose
- Prevention
- FDA-regulated drug
- No
- Who can join
- All sexes
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Venous thromboembolism (VTE) has a high prevalence in patients with multiple comorbidities undergoing complex surgical procedures. Sometimes, extended prophylaxis for VTE with KLMWH or direct oral anticoagulants (DOACs) is necessary. Currently, there is no consensus in the literature regarding the use of DOACs for extended VTE prophylaxis in patients undergoing lower limb revascularization (LLR). Objective: To evaluate the use of DOACs (already approved to reduce MACE and MALE) in VTE prophylaxis in patients undergoing LLR.
Conditions
- Peripheral Arterial Disease
- Venous Thormboembolism
- Cardiovascular Diseases
- Vascular Surgery Patient with PAD / Carotid Stenosis
Interventions
rivaroxaban 2.5 mg bid + aspirin 100 mgDrug
rivaroxaban 2.5 mg bid + aspirin
clopidogrel 75 mg od for 3 months followed by aspirin 100 mg od for endovascular procedures or aspirin for open proceduresDrug
comparator
Primary outcomes
What the sponsor says the trial is designed to measure.
- primary efficacy outcomeTime frame: 30 days
- primary safety outcomeTime frame: 30 days
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Hospital das Clínicas, Federal University of Pernambuco
Pernambuco, Pernambuco, Brazil · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.